Skip to content

High prevalence of resistance to zidovudine among people in sub-Saharan Africa experiencing virological failure with tenofovir-containing ART

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

Eric Daar at IDWeek 2016. Photo by Liz Highleyman, hivandhepatitis.com

Darunavir/ritonavir & lamivudine matches triple-drug therapy

Jose Arribas speaking at HIV Glasgow. Image credit: HIV Drug Therapy Glasgow 2016

Two-drug HIV therapy just as effective as three-drug therapy

Roberta Gagliardini speaking at HIV Glasgow. Image credit: HIV Drug Therapy Glasgow 2016

Doctors in Netherlands observe higher than expected dolutegravir treatment discontinuation rate

Spanish study gives reassurance: small HIV blips do not predict treatment failure

Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

HIV salvage regimens can safely omit NRTIs, says US study